%PDF-1.3
%
1 0 obj
<<
/Pages 2 0 R
/Type /Catalog
/PageLabels 3 0 R
/Metadata 4 0 R
>>
endobj
5 0 obj
<<
/XPressPrivate <2525446F63756D656E7450726F63657373436F6C6F72733A20426C61636B0A2525456E64436F6D6D656E7473>
/Producer (QuarkXPress\(tm\) 6.5)
/CreationDate (20070723095426)
/Creator (QuarkXPress\(tm\) 6.5)
/ModDate (D:20220412194433+00'00')
>>
endobj
2 0 obj
<<
/Type /Pages
/Kids [6 0 R 7 0 R 8 0 R]
/Count 3
>>
endobj
3 0 obj
<<
/Nums [0 9 0 R]
>>
endobj
4 0 obj
<<
/Type /Metadata
/Subtype /XML
/Length 934
>>
stream
Not for further distribution unless allowed by the License or with the express written permission of Cambridge University Press.
https://doi.org/10.1017/S0317167100006739
https://doi.org/10.1017/S0317167100006739 Published online by Cambridge University Press
2022-04-12T19:44:33+00:00
endstream
endobj
6 0 obj
<<
/Parent 2 0 R
/Type /Page
/MediaBox [0 0 594 783]
/Resources <<
/ProcSet [/PDF /Text]
/Font <<
/F2 10 0 R
/F3 11 0 R
/F0 12 0 R
/F1 13 0 R
/F5 14 0 R
>>
/ExtGState <<
/GS0 15 0 R
/GS1 16 0 R
/GS2 17 0 R
>>
>>
/Contents [18 0 R 19 0 R 20 0 R]
/Annots [21 0 R]
>>
endobj
7 0 obj
<<
/Parent 2 0 R
/Type /Page
/MediaBox [0 0 594 783]
/Resources <<
/XObject <<
/Fm0 22 0 R
>>
/ProcSet [/PDF /Text]
/Font <<
/F2 10 0 R
/F8 23 0 R
/F3 11 0 R
/F0 12 0 R
/F1 13 0 R
/F6 14 0 R
>>
/ExtGState <<
/GS0 15 0 R
/GS1 16 0 R
/GS2 17 0 R
>>
>>
/Contents [24 0 R 25 0 R 26 0 R]
/Annots [27 0 R]
>>
endobj
8 0 obj
<<
/Parent 2 0 R
/Type /Page
/MediaBox [0 0 594 783]
/Resources <<
/ProcSet [/PDF /Text]
/Font <<
/F8 23 0 R
/F3 11 0 R
/F0 12 0 R
/F1 13 0 R
/F5 14 0 R
>>
/ExtGState <<
/GS0 15 0 R
/GS1 16 0 R
/GS2 17 0 R
>>
>>
/Contents [28 0 R 29 0 R 30 0 R]
/Annots [31 0 R]
>>
endobj
9 0 obj
<<
/St 313
/S /D
>>
endobj
10 0 obj
<<
/Widths [250 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 333 0 0 0
0 0 0 0 667 667 0 0 667 0
0 0 0 0 0 889 0 0 611 0
667 0 0 0 0 0 0 0 0 0
0 0 0 0 0 500 500 444 500 444
333 500 556 278 278 500 278 0 556 500
500 0 389 389 278 556 0 0 500 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
444]
/LastChar 142
/FirstChar 32
/Type /Font
/FontDescriptor 32 0 R
/BaseFont /FLFRTK+Times-BoldItalic
/Encoding 33 0 R
/Name /F2
/Subtype /Type1
>>
endobj
11 0 obj
<<
/Widths [250 0 0 0 0 0 0 0 333 333
0 0 250 333 250 278 500 500 500 500
500 500 0 500 0 0 333 333 0 0
0 0 0 611 611 667 722 0 0 0
0 0 444 0 556 0 667 0 0 0
611 500 556 0 611 0 0 556 0 0
0 0 0 0 0 500 500 444 500 444
278 500 500 278 0 0 278 722 500 500
500 500 389 389 278 500 444 667 444 444
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 500]
/LastChar 208
/FirstChar 32
/Type /Font
/FontDescriptor 34 0 R
/BaseFont /TBSYQH+Times-Italic
/Encoding 35 0 R
/Name /F3
/Subtype /Type1
>>
endobj
12 0 obj
<<
/Widths [250 0 0 500 0 833 0 180 333 333
0 0 250 333 250 278 500 500 500 500
500 500 500 500 500 500 278 278 0 0
0 0 0 722 667 667 722 611 556 722
722 333 389 722 611 889 722 722 556 722
667 556 611 722 722 944 0 722 611 0
0 0 0 0 0 444 500 444 500 444
333 500 500 278 278 500 278 778 500 500
500 500 333 389 278 500 500 722 500 500
444 0 0 0 0 0 0 0 0 0
0 0 0 0 444 0 0 0 0 0
444 444 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 333]
/LastChar 213
/FirstChar 32
/Type /Font
/FontDescriptor 36 0 R
/BaseFont /VOZEJR+Times-Roman
/Encoding 37 0 R
/Name /F0
/Subtype /Type1
>>
endobj
13 0 obj
<<
/Widths [250 0 0 0 0 0 0 0 0 0
0 0 0 332 250 0 0 0 0 0
0 0 0 0 0 0 332 0 0 0
0 0 0 721 666 721 721 666 610 776
0 388 0 0 666 942 721 776 0 0
721 555 666 721 721 0 0 0 0 0
0 0 0 0 0 499 0 443 555 443
332 0 555 277 0 555 277 831 555 499
555 555 443 388 332 555 499 0 0 499
443 0 0 0 0 0 0 0 0 666
0 0 0 0 0 0 0 0 0 0
443 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 332]
/LastChar 213
/FirstChar 32
/Type /Font
/FontDescriptor 38 0 R
/BaseFont /EXEQBN+Times-Bold
/Encoding 39 0 R
/Name /F1
/Subtype /Type1
>>
endobj
14 0 obj
<<
/Type /Font
/BaseFont /AAANBE+NotoSans
/Subtype /Type0
/Encoding /Identity-H
/DescendantFonts [40 0 R]
/ToUnicode 41 0 R
>>
endobj
15 0 obj
<<
/OPM 1
/Type /ExtGState
>>
endobj
16 0 obj
<<
/OP true
/Type /ExtGState
>>
endobj
17 0 obj
<<
/OP false
/Type /ExtGState
>>
endobj
18 0 obj
<<
/Filter /FlateDecode
/Length 10
>>
stream
x+ |
endstream
endobj
19 0 obj
<<
/Length 10154
>>
stream
/GS0 gs
1 g
0 783 0 0 re
f
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 52.3994 216.5034 Tm
0 0 0 1 k
0.014 Tc
0.361 Tw
(Clinical and electrophysiological studies reveal a high)Tj
-1.26316 -1.15789 TD
0 Tc
0.142 Tw
(incidence of nervous system dysfunction in patients treated in)Tj
0 -1.1579 TD
0.081 Tw
[(major medical and sur)18(gical intensive care units \(ICU\325)55(s\).)]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 258.2333 197.6386 Tm
0 0 0 1 k
(1,2)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 269.0482 194.5034 Tm
0 0 0 1 k
(This)Tj
-24.06829 -1.15789 TD
0.044 Tw
[(dysfunction is especially common in patients who suf)18(fer from a)]TJ
T*
0.126 Tw
(systemic inflammatory response syndrome (SIRS) as a critical)Tj
0 -1.1579 TD
0 Tw
(illness.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 67.0485 164.6386 Tm
0 0 0 1 k
(3)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 75.0566 161.5034 Tm
0 0 0 1 k
0.006 Tw
(Systemic inflammatory response syndrome occurs in at)Tj
-3.64813 -1.15789 TD
0.08 Tw
(least 50% of patients who are treated on ventilators in the ICU)Tj
T*
0.222 Tw
(for more than one week.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 141.4193 142.6386 Tm
0 0 0 1 k
(4)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 149.0397 139.5035 Tm
0 0 0 1 k
0.222 Tw
(Septic encephalopathy and critical)Tj
-11.43582 -1.1579 TD
0.005 Tc
0.37 Tw
(illness polyneuropathy (CIP) both occur in 70% of SIRS)Tj
0 -1.15789 TD
0 Tc
0 Tw
(patients.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 72.3204 120.6386 Tm
0 0 0 1 k
(5)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 79.5945 117.5034 Tm
0 0 0 1 k
0.186 Tw
(Critical illness myopathy is especially prominent in)Tj
-4.1258 -1.15789 TD
0.003 Tc
0.372 Tw
[(patients who, in addition to suf)18(fering from SIRS, receive)]TJ
0 -1.1579 TD
0 Tc
0.011 Tw
(neuromuscular blocking agents and steroids.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 209.9076 98.6386 Tm
0 0 0 1 k
(6)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 220.3076 95.5034 Tm
0 0 0 1 k
0.011 Tw
(The amplitude of)Tj
-18.93771 -1.15789 TD
0.008 Tc
0.367 Tw
(the QRS complex in the electrocardiogram is reduced in)Tj
T*
0 Tc
0.025 Tw
(critically ill patients.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 119.2216 76.6386 Tm
0 0 0 1 k
(7)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F1 1 Tf
9.5 0 0 9.5 159.5244 570.2967 Tm
0 0 0 1 k
0.001 Tc
[(ABSTRACT)75(:)]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F2 1 Tf
9.5 0 0 9.5 215.9747 570.2967 Tm
0 0 0 1 k
-0.011 Tw
(Background and Purpose:)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 321.3026 570.2967 Tm
0 0 0 1 k
-0.011 Tw
[(The central and peripheral nervous systems are often af)18(fected)]TJ
-17.02929 -1.15789 TD
0.048 Tw
(in intensive care unit (ICU) patients, especially those with prolonged assisted ventilation and sepsis or)Tj
0 -1.1579 TD
0.049 Tw
[(systemic inflammatory response syndrome (SIRS). )18(The autonomic nervous system, however)39(, has been)]TJ
0 -1.15789 TD
0.007 Tw
[(under)20(-investigated in such patients. )17(W)80(e evaluated autonomic nervous system (ANS) function in 29 ICU)]TJ
T*
0.027 Tw
(patients with various neurological disorders. )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F2 1 Tf
9.5 0 0 9.5 331.727 526.2967 Tm
0 0 0 1 k
(Methods: )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 371.2919 526.2967 Tm
0 0 0 1 k
0.027 Tw
[(T)70(esting involved cardiac R-R variation \(CRR)80(V\))]TJ
-22.29132 -1.1579 TD
0.188 Tw
(as an index of parasympathetic function and the sympathetic skin response (SSR) for sympathetic)Tj
T*
0 Tw
(assessment. )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F2 1 Tf
9.5 0 0 9.5 208.8596 504.2966 Tm
0 0 0 1 k
(Results:)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 245.2761 504.2966 Tm
0 0 0 1 k
0.25 Tw
(Only those 8 patients with sepsis-related neuropathy or encephalopathy had)Tj
-9.02649 -1.15789 TD
0.077 Tw
[(abnormal CRR)80(V)129(, while the SSR was absent in all but 2 patients. )]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F2 1 Tf
9.5 0 0 9.5 413.2435 493.2967 Tm
0 0 0 1 k
(Conclusions:)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 468.0732 493.2967 Tm
0 0 0 1 k
0.077 Tw
(Our preliminary study)Tj
-32.47882 -1.1579 TD
-0.015 Tw
(revealed a high incidence of autonomic dysfunction in ICU patients with various neurological disorders.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F1 1 Tf
8.5 0 0 8.5 159.5244 447.2967 Tm
0 0 0 1 k
0.001 Tc
(R\203SUM\203: )Tj
4.82716 0 TD
-0.033 Tw
(La variation cardiaque R-R et la r\216ponse cutan\216e sympathique chez des patients de l\325unit\216 de soins)Tj
-4.82716 -1.29412 TD
-0.014 Tw
(intensifs. )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F2 1 Tf
8.5 0 0 8.5 195.8683 436.2967 Tm
0 0 0 1 k
-0.014 Tw
(Contexte et objectif :)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
8.5 0 0 8.5 269.9611 436.2967 Tm
0 0 0 1 k
-0.014 Tw
(Le syst\217me nerveux central et le syst\217me nerveux p\216riph\216rique sont souvent atteints)Tj
-12.99255 -1.29412 TD
0.054 Tw
(chez les patients hospitalis\216s \210 l\325unit\216 de soins intensifs (USI), surtout chez ceux qui sont sous ventilation assist\216e)Tj
T*
0.058 Tw
(prolong\216e et ceux qui sont atteints de septic\216mie ou d\325un syndrome de r\216action inflammatoire g\216n\216ralis\216e (SIRS).)Tj
T*
0.039 Tw
(Cependant, le syst\217me nerveux autonome (SNA) a \216t\216 peu \216tudi\216 chez ces patients. Nous avons \216tudi\216 la fonction)Tj
T*
0.01 Tw
[(du SNA)-205(chez 29 patients de l\325USI atteints de dif)17(f\216rents probl\217mes neurologiques. )]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F2 1 Tf
8.5 0 0 8.5 441.388 392.2967 Tm
0 0 0 1 k
0.01 Tw
(M\216thodes : )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
8.5 0 0 8.5 482.6359 392.2967 Tm
0 0 0 1 k
0.01 Tw
(Nous avons \216tudi\216 la)Tj
-38.01312 -1.29412 TD
0.32 Tw
(variation de l\325intervalle R-R (VIRR) comme indice de la fonction parasympathique et la r\216ponse cutan\216e)Tj
T*
0.184 Tw
(sympathique (RCS) pour la fonction sympathique. )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F2 1 Tf
8.5 0 0 8.5 346.0898 370.2967 Tm
0 0 0 1 k
0.184 Tw
(R\216sultats :)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
8.5 0 0 8.5 388.4063 370.2967 Tm
0 0 0 1 k
0.184 Tw
(Seuls les 8 patients atteints de neuropathie ou)Tj
-26.92728 -1.29412 TD
0.062 Tw
[(d\325enc\216phalopathie reli\216e \210 une septic\216mie avaient une )18(VIRR anormale et la RCS \216tait pr\216sente chez deux patients)]TJ
T*
0 Tw
(seulement. )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F2 1 Tf
8.5 0 0 8.5 200.5995 348.2967 Tm
0 0 0 1 k
0.014 Tw
(Conclusions :)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
8.5 0 0 8.5 251.3719 348.2967 Tm
0 0 0 1 k
0.014 Tw
(Cette \216tude pr\216liminaire a r\216v\216l\216 une incidence \216lev\216e de dysfonction autonome chez les)Tj
-10.80559 -1.29412 TD
0.025 Tw
[(patients atteints de dif)18(f\216rents troubles neurologiques qui sont hospitalis\216s \210 l\325USI. )]TJ
ET
1 w
0 0 0 1 K
39.524 266.797 m
553.948 266.797 l
S
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 405.8225 285.2967 Tm
0 0 0 1 k
0.025 Tw
(Can. J. Neurol. Sci. 2007; 34: 313-315)Tj
ET
0 0 0 0 k
39.297 27.493 516.875 42 re
f
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9 0 0 9 39.2971 29.4446 Tm
0 0 0 1 k
-0.0001 Tc
(THE)Tj
2.21865 0 Td
0 Tc
0.025 Tw
[(CANADIAN JOURNAL)-238(OF NEUROLOGICAL)-238(SCIENCES)-28963(313)]TJ
ET
4 w
0 0 0 1 K
159.431 749.494 m
554.806 749.494 l
S
Q
/GS2 gs
/GS1 gs
q
BT
/F1 1 Tf
22 0 0 22 159.4306 719.4942 Tm
0 0 0 1 k
0.001 Tc
0.025 Tw
[(The Cardiac R-R )19(V)91(ariation and)]TJ
0 -1.18182 TD
(Sympathetic Skin Response in the)Tj
0 -1.18181 TD
[(Intensive Car)19(e Unit )]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F3 1 Tf
12 0 0 12 159.4306 637.4941 Tm
0 0 0 1 k
0.025 Tw
[(Charles Bolton, Jillian Thompson, Linda Bernar)37(di, Christopher V)111(oll, )]TJ
ET
1 w
0 0 0 1 K
39.431 602.994 m
554.806 602.994 l
S
BT
/F3 1 Tf
12 0 0 12 159.4306 621.4942 Tm
[(Bryan Y)92(oung )]TJ
ET
0 0 0 0 k
309.289 70.3 245.687 74.193 re
f
309.289 130.3179 m
554.976 130.3179 l
S
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
7 0 0 7 309.289 111.8176 Tm
0 0 0 1 k
0.025 Tw
[(From the Division of Neurology)65(, University of )18(W)80(estern Ontario \(CB, JT)73(, LB, BY\),)]TJ
0 -1.14286 TD
[(London, Ontario; )18(The University of Saskatchewan (CV), Saskatoon, Saskatchewan,)]TJ
0 -1.14285 TD
0 Tw
(Canada.)Tj
1.71429 -1.14286 TD
(R)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
5.25 0 0 5.25 325.9579 87.8176 Tm
0 0 0 1 k
(ECEIVED)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
7 0 0 7 350.3326 87.8176 Tm
0 0 0 1 k
(N)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
5.25 0 0 5.25 355.3861 87.8176 Tm
0 0 0 1 k
(OVEMBER)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
7 0 0 7 382.9753 87.8176 Tm
0 0 0 1 k
0.025 Tw
(6, 2006. )Tj
3.49507 0.00001 TD
(A)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
5.25 0 0 5.25 412.4943 87.8176 Tm
0 0 0 1 k
(CCEPTED)Tj
4.81101 0.00001 TD
(IN)Tj
1.42135 0.00001 TD
(FINAL)Tj
3.27316 0.00001 TD
(FORM)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
7 0 0 7 479.2005 87.8176 Tm
0 0 0 1 k
(M)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
5.25 0 0 5.25 485.4229 87.8176 Tm
0 0 0 1 k
(ARCH)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
7 0 0 7 501.9315 87.8176 Tm
0 0 0 1 k
(19,)Tj
1.52499 0 Td
(2007.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F3 1 Tf
7 0 0 7 309.289 79.8176 Tm
0 0 0 1 k
0.025 Tw
[(Reprint r)37(equests to:)]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
7 0 0 7 368.826 79.8176 Tm
0 0 0 1 k
0.025 Tw
[(G.B. )37(Y)100(oung, Department of Clinical Neurological Sciences,)]TJ
-8.50529 -1.14285 TD
(University Hospital, 339 )Tj
10.16631 0.00001 TD
[(W)40(indermere Road, London, Ontario, N6A)-220(5A5, Canada.)]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F1 1 Tf
9 0 0 9 39.4306 741.3389 Tm
0 0 0 1 k
0.0013 Tc
(O)Tj
0.77732 0.00001 TD
0.001 Tc
[(RIGINAL)-164(A)-1(R)36(TICLE)]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 321.5354 216.5034 Tm
0 0 0 1 k
0.16 Tw
(Since SIRS has widespread central and peripheral nervous)Tj
-1.26316 -1.15789 TD
0.126 Tw
[(system ef)18(fects, we decided to examine the autonomic nervous)]TJ
0 -1.1579 TD
0.077 Tw
[(system prospectively)65(. )18(The parasympathetic nervous system can)]TJ
0 -1.15789 TD
-0.011 Tw
[(be assessed by measuring the cardiac R-R variation \(CRR)80(V\) and)]TJ
T*
0.02 Tc
0.53 Tw
(the sympathetic pathways are evaluated by using the)Tj
ET
0.5 w
0 0 0 1 K
159.3038 751.2395 m
39.3998 751.2395 l
S
/GS2 gs
Q
endstream
endobj
20 0 obj
<<
/Filter /FlateDecode
/Length 238
>>
stream
xmK0[n2PrdI&ulvhalnu^R /{bى})buz)ǓJk[Z9tc!&yEPJ'[ITwPMό'9
Θ{>
endobj
22 0 obj
<<
/Name /Fm0
/BBox [0 0 593.99994 782.99994]
/Subtype /Form
/Resources <<
/XObject <<
/Fm1 43 0 R
>>
/ProcSet [/PDF]
/ExtGState <<
/GS3 44 0 R
>>
>>
/Type /XObject
/Length 65
/Matrix [1 0 0 1 0 0]
/OPI <<
/1.3 <<
/ImageType [1 1]
/Resolution [1200 1200]
/Version 1.3
/Size [3612 3494]
/CropRect [50 0 3564 3494]
/CropFixed [49.696 0 3564.05298 3494]
/Overprint false
/Type /OPI
/F (Production-HD:Users:Production:Production Documents:Production Documents: Journal in Progress: 34#3 Aug 2007:figures tables:3142 ANS fig1.tif)
/ColorType /Process
/Position [90.7 513 503.405 513 503.405 97.837 90.7 97.837]
/Color [0 0 0 1 (Black)]
>>
>>
/FormType 1
>>
stream
/GS3 gs
q
0 -415.59079 412.75861 0 90.5948 513.1983 cm
/Fm1 Do
Q
endstream
endobj
23 0 obj
<<
/Widths [250 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 576]
/LastChar 109
/FirstChar 32
/Type /Font
/FontDescriptor 45 0 R
/BaseFont /UQKHTT+Symbol
/Encoding 46 0 R
/Name /F8
/Subtype /Type1
>>
endobj
24 0 obj
<<
/Filter /FlateDecode
/Length 10
>>
stream
x+ |
endstream
endobj
25 0 obj
<<
/Length 5299
>>
stream
/GS0 gs
1 g
0 783 0 0 re
f
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 40.024 717.0228 Tm
0 0 0 1 k
0.012 Tc
0.362 Tw
(sympathetic skin response (SSR) that mediates cutaneous)Tj
0 -1.15789 TD
0 Tc
0.018 Tw
[(choliner)18(gic (sudomotor) function via both central and peripheral)]TJ
T*
0 Tw
(pathways.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 78.2745 698.1578 Tm
0 0 0 1 k
-0.0001 Tc
(8)Tj
0.49992 -0.00001 TD
0 Tc
(-10)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 94.9982 695.0228 Tm
0 0 0 1 k
0.319 Tw
[(The CRR)80(V)-551(and SSR have been shown to be)]TJ
-5.78676 -1.1579 TD
-0.001 Tw
(abnormal in patients outside the ICU who have a wide variety of)Tj
0 -1.15789 TD
0.025 Tw
[(disorders af)18(fecting these pathways.)]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 174.0288 676.1578 Tm
0 0 0 1 k
[(9,1)56(1)]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F1 1 Tf
9.5 0 0 9.5 40.024 651.0228 Tm
0 0 0 1 k
0.001 Tc
(Methods)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 52.024 636.0228 Tm
0 0 0 1 k
0.223 Tw
(Studies were performed on patients in a 30 bed medical-)Tj
-1.26316 -1.15789 TD
0.02 Tc
0.989 Tw
[(sur)18(gical ICU. Neurological and electrophysiological)]TJ
T*
0 Tc
0.044 Tw
(consultations were requested to investigate a variety of possible)Tj
0 -1.1579 TD
0.017 Tw
(central and peripheral nervous system (CNS and PNS) disorders)Tj
0 -1.15789 TD
0.02 Tc
0.478 Tw
(according to previously documented techniques.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 250.7843 595.1578 Tm
0 0 0 1 k
0.02 Tc
(1)Tj
0.52 -0.00001 TD
(2)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 264.4085 592.0228 Tm
0 0 0 1 k
0.02 Tc
(Limb)Tj
-23.61942 -1.15789 TD
0.013 Tc
0.362 Tw
[(temperature was monitored routinely)65(. For CNS disorders,)]TJ
0 -1.1579 TD
0.02 Tc
0.359 Tw
(somatosensory evoked potentials were utilized. For PNS)Tj
0 -1.15789 TD
0 Tc
0.169 Tw
(disorders motor and sensory nerve conduction and the needle)Tj
28.33011 16.63158 TD
0.168 Tw
[(electrode myography were used. )18(There were 18 men and 15)]TJ
0 -1.15789 TD
0.107 Tw
[(women ranging in age from 19 to 83 years of age; 1)37(1 patients)]TJ
T*
0.37 Tw
[(were over 60 years of age. )18(The predominant neurological)]TJ
0 -1.1579 TD
0.314 Tw
(diagnoses were septic encephalopathy (2), anoxic- ischemic)Tj
0 -1.15789 TD
0.111 Tw
(encephalopathy (1), Parkinson disease (1), drug induced extra-)Tj
T*
0.02 Tc
0.535 Tw
(pyramidal syndrome (1), traumatic encephalopathy (3),)Tj
0 -1.1579 TD
0 Tc
0.106 Tw
(traumatic quadriplegia (2), critical illness polyneuropathy (14),)Tj
0 -1.15789 TD
0.224 Tw
[(and myopathy (5). )55(At the time of testing patients were not)]TJ
T*
0.371 Tw
[(receiving adrener)18(gic blockers or drugs with anticholiner)17(gic)]TJ
0 -1.1579 TD
0.175 Tw
[(properties that might af)18(fect the CRR)79(V)-407(and SSR. Critically ill)]TJ
0 -1.15789 TD
0.085 Tw
[(patients had widespread or)18(gan dysfunction, glucose intolerance)]TJ
T*
0.029 Tw
[(and other manifestations of SIRS. )18(They had a variety of reasons)]TJ
0 -1.1579 TD
0.025 Tw
(for ICU admission.)Tj
1.26316 -1.15789 TD
0.013 Tw
[(Both the CRR)80(V)-245(and the SSR were measured according to the)]TJ
-1.26316 -1.15789 TD
0.01 Tc
0.365 Tw
(technique of Shahani et al,)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 426.6207 566.1578 Tm
0 0 0 1 k
0.01 Tc
(10)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 438.9534 563.0228 Tm
0 0 0 1 k
0.01 Tc
0.365 Tw
(and were performed on an)Tj
ET
0 0 0 0 k
39.696 726 516 30 re
f
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9 0 0 9 39.696 749.8455 Tm
0 0 0 1 k
-0.0001 Tc
(THE)Tj
2.21865 0 Td
0 Tc
0.025 Tw
[(CANADIAN JOURNAL)-238(OF NEUROLOGICAL)-238(SCIENCES)]TJ
-2.21865 -80.04603 TD
(314)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F2 1 Tf
8.5 0 0 8.5 39.024 84.7844 Tm
0 0 0 1 k
(Figure:)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F3 1 Tf
8.5 0 0 8.5 69.9871 84.7844 Tm
0 0 0 1 k
-0.012 Tw
(The normal r)Tj
5.21693 0.00001 TD
(esult in healthy persons is shown in )Tj
14.37047 0.00001 TD
(A)Tj
0.83125 0.00001 TD
[(for the CRR)18(V)-221(and C for the SSR \(upper trace is for the hand and )1(the lower trace is the foot.\))]TJ
-24.06137 -1.05884 TD
0.024 Tw
(The abnormal r)Tj
6.28914 0.00001 TD
(esponse for the CRR)Tj
8.24779 0.00001 TD
(V)Tj
0.86735 0.00001 TD
[(is shown in B \(a fixed R-R interval\) and for SSR in D \(absent r)37(esponse fr)36(om the hand )1(and foot.\) \(Calibration )17(A-)]TJ
-15.40428 -1.05884 TD
0.025 Tw
(200 ms and 200 )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F8 1 Tf
8.5 0 1.80673 8.5 96.0662 66.7844 Tm
0 0 0 1 k
(m)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F3 1 Tf
8.5 0 0 8.5 100.9636 66.7844 Tm
0 0 0 1 k
0.025 Tw
(V/div; B-200 ms and 100 )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F8 1 Tf
8.5 0 1.80673 8.5 189.1304 66.7844 Tm
0 0 0 1 k
(m)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F3 1 Tf
8.5 0 0 8.5 194.0279 66.7844 Tm
0 0 0 1 k
0.025 Tw
(V/div; C-1.0 sec and 500 )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F8 1 Tf
8.5 0 1.80673 8.5 281.956 66.7844 Tm
0 0 0 1 k
(m)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F3 1 Tf
8.5 0 0 8.5 286.8535 66.7844 Tm
0 0 0 1 k
0.025 Tw
(V/div; D \320 1.0 sec and 200 )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F8 1 Tf
8.5 0 1.80673 8.5 381.3451 66.7844 Tm
0 0 0 1 k
(m)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F3 1 Tf
8.5 0 0 8.5 386.2425 66.7844 Tm
0 0 0 1 k
(V/div)Tj
2.03639 0.00001 TD
(.\))Tj
ET
/GS2 gs
q
39.024 97.8369 515.952 415.1631 re
W n
/Fm0 Do
Q
Q
endstream
endobj
26 0 obj
<<
/Filter /FlateDecode
/Length 238
>>
stream
xmK0[n2PrdI&ulvhaLnu^Z /{bK/ӻX_q_/pZim>VR+.c,| Dcw#O*T V8Ux]t62[<8gأsri9.ɞ|s\Ly#qu'ӧX?ZAc:%%|2X`--zmhѦ:-9puv(r+~mZ
7X7
endstream
endobj
27 0 obj
<<
/Type /Annot
/Subtype /Link
/Rect [7.7999997 14.264648 133.62 22.189453]
/Border [0 0 0]
/A 47 0 R
>>
endobj
28 0 obj
<<
/Filter /FlateDecode
/Length 10
>>
stream
x+ |
endstream
endobj
29 0 obj
<<
/Length 13609
>>
stream
/GS0 gs
1 g
0 783 0 0 re
f
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 40.024 717.024 Tm
0 0 0 1 k
0.027 Tw
(Advantage EMG system \(Advantage Medical, London, Ontario,)Tj
0 -1.1579 TD
0.194 Tw
(Canada\) with special software designed for these procedures.)Tj
0 -1.15789 TD
0.045 Tw
(Each patient was on a ventilator and testing was done while the)Tj
T*
0.103 Tw
[(ventilator was operating. )18(The SSR was tested before any other)]TJ
0 -1.1579 TD
0.269 Tw
[(stimulus was given to the patient to avoid habituation. )18(The)]TJ
0 -1.15789 TD
-0.0001 Tc
(s)Tj
0.3889 -0.00001 TD
0 Tc
0.302 Tw
(timulus was applied to the left median nerve at the wrist)Tj
-0.3889 -1.15789 TD
-0.001 Tw
(randomly with duration of 0.2 milliseconds and 15-50 milliamps)Tj
T*
0.245 Tw
[(intensity)65(. Five sets of stimuli were given at greater than 30)]TJ
0 -1.1579 TD
0.019 Tw
(second intervals. Responses were recorded simultaneously with)Tj
0 -1.15789 TD
0.173 Tw
(surface electrodes over the contralateral palm and sole of the)Tj
T*
0.048 Tw
(foot. Sympathetic skin response was performed at filter settings)Tj
0 -1.1579 TD
0.039 Tw
(between 0.5 and 100 Hz and gain between 200 and 500 )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F8 1 Tf
9.5 0 0 9.5 256.6914 596.024 Tm
0 0 0 1 k
(m)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 262.165 596.024 Tm
0 0 0 1 k
[(V/div)65(.)]TJ
-23.38326 -1.15789 TD
0.135 Tw
(Sympathetic skin response was considered abnormal only if it)Tj
T*
0.088 Tw
(was entirely absent at both the hand and the foot. Cardiac R-R)Tj
0 -1.1579 TD
-0.037 Tw
(variation was then tested, with filter settings between 0.5 and 100)Tj
0 -1.15789 TD
-0.0001 Tc
(Hz)Tj
1.38653 0 Td
0 Tc
-0.029 Tw
(and gain from 100-500 )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F8 1 Tf
9.5 0 0 9.5 141.7788 552.024 Tm
0 0 0 1 k
(m)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 147.2525 552.024 Tm
0 0 0 1 k
-0.029 Tw
[(V/div)65(, and expressed as a percentage)]TJ
-11.28721 -1.15789 TD
0.086 Tw
(of the average RR interval and was considered abnormal if the)Tj
0 -1.1579 TD
0.09 Tw
(variation was less than either 12% or less than 5% for patients)Tj
T*
0.025 Tw
(over 60 years of age.)Tj
1.26316 -1.15789 TD
(T)Tj
0.54101 -0.00001 TD
0.116 Tw
(wo patients, who had been studied while on ventilators in)Tj
-1.80417 -1.15788 TD
0.073 Tw
[(the ICU and were found to have absent SSR\325)55(s, were tested one)]TJ
0 -1.15789 TD
0.025 Tw
(month after dischar)Tj
7.8061 0 TD
(ge from the ICU while of)Tj
10.24196 0 TD
-0.0001 Tc
(f)Tj
0.60776 0 Td
0 Tc
[(the ventilator)55(. )]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F1 1 Tf
9.5 0 0 9.5 40.024 464.024 Tm
0 0 0 1 k
(R)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F1 1 Tf
7.125 0 0 7.125 46.8823 464.024 Tm
0 0 0 1 k
0.001 Tc
(ESUL)Tj
2.52001 0 TD
0.0019 Tc
(T)Tj
0.6679 -0.00001 TD
(S)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 52.024 449.024 Tm
0 0 0 1 k
0.01 Tw
[(Eight of the 29 patients had an abnormal CRR)80(V)-243((Figure). Six)]TJ
-1.26316 -1.1579 TD
0.075 Tw
[(of these had CIP)-289((mild in 5 and moderate in 1) and 2 had mild)]TJ
0 -1.15789 TD
0.222 Tw
(septic encephalopathy)Tj
9.01397 0 TD
(.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 128.0317 430.159 Tm
0 0 0 1 k
(1)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 139.9605 427.024 Tm
0 0 0 1 k
0.222 Tw
(The SSR was absent (Figure) in all)Tj
-10.51963 -1.1579 TD
-0.026 Tw
(patients (see list in methods) except for a 73 year old female with)Tj
T*
0.063 Tw
[(anoxic-ischemic encephalopathy)65(, and a 54 year old female who)]TJ
0 -1.15789 TD
0.073 Tw
(was on the ventilator briefly for a drug-induced extrapyramidal)Tj
0 -1.1579 TD
0.025 Tw
(syndrome. )Tj
1.26316 -1.1579 TD
0.057 Tw
(The median nerve sensory action potential (SNAP) recorded)Tj
-1.26316 -1.15789 TD
0.194 Tw
(at the index finger from wrist stimulation was normal in 21,)Tj
0 -1.1579 TD
0.068 Tw
(reduced in 1, absent in 1 and, for several technical reasons, not)Tj
T*
0.025 Tw
(tested in 6 patients.)Tj
1.26316 -1.15789 TD
(T)Tj
0.54101 0 TD
0.278 Tw
(wo patients with moderate/severe CIP)Tj
16.81963 0 TD
(had absent SSRs)Tj
-18.6238 -1.1579 TD
0.105 Tw
(while on the ventilator in the ICU and when tested one month)Tj
T*
0.025 Tw
[(later)40(, while of)17(f the ventilator)55(.)]TJ
1.26316 -1.15789 TD
0.196 Tw
(The typical results of the CRR)Tj
13.09349 0 TD
[(V)-428(and the SSR for healthy)]TJ
-14.35665 -1.1579 TD
0.025 Tw
(persons and patients are shown in the Figure. )Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F1 1 Tf
9.5 0 0 9.5 40.024 262.0239 Tm
0 0 0 1 k
(D)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F1 1 Tf
7.125 0 0 7.125 46.8823 262.0239 Tm
0 0 0 1 k
0.001 Tc
(ISCUSSION)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 52.024 247.0239 Tm
0 0 0 1 k
0.002 Tc
0.373 Tw
(The study revealed a high incidence of dysfunction in)Tj
-1.26316 -1.15789 TD
0.02 Tc
0.387 Tw
(critically ill patients involving both the parasympathetic)Tj
T*
0 Tc
0.228 Tw
[(\(measured by the CRR)80(V\) and sympathetic \(measured by the)]TJ
0 -1.1579 TD
-0.02 Tw
(SSR\) pathways, in the central and peripheral nervous systems. It)Tj
0 -1.15789 TD
0.03 Tw
(is known that sepsis SIRS causes widespread dysfunction of the)Tj
T*
0.006 Tc
0.369 Tw
(brain, peripheral nerve and muscle in the form of septic)Tj
0 -1.1579 TD
0 Tc
0.048 Tw
[(encephalopathy)65(, critical illness polyneuropathy and myopathy)65(.)]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 279.2899 184.159 Tm
0 0 0 1 k
(13)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 40.024 170.024 Tm
0 0 0 1 k
0.0177 Tc
(It)Tj
1.27141 0 Td
0.018 Tc
0.357 Tw
(has been shown that cardiac muscle is also involved)Tj
-1.27141 -1.15789 TD
0 Tc
0.008 Tw
(manifested as reduction in the amplitude of the QRS complex of)Tj
0 -1.1579 TD
0.02 Tw
(the electrocardiogram.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 125.6582 151.159 Tm
0 0 0 1 k
(7)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 131.3558 148.0239 Tm
0 0 0 1 k
0.02 Tw
(Examination of the sympathetic chain at)Tj
-9.61387 -1.15789 TD
0.163 Tw
(autopsy in critically ill patients reveals axonal degeneration.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 279.2901 140.159 Tm
0 0 0 1 k
(12)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 40.024 126.024 Tm
0 0 0 1 k
(However)Tj
3.62452 0.00001 TD
-0.0001 Tc
(,)Tj
0.69162 0 Td
0 Tc
0.192 Tw
(studies have not been previously performed on the)Tj
-4.31613 -1.15791 TD
0.197 Tw
(parasympathetic connections to the heart and it has not been)Tj
0 -1.15789 TD
0.008 Tc
0.367 Tw
(previously determined whether unmyelinated fibres of the)Tj
T*
0 Tc
0.043 Tw
(peripheral nervous system are involved. )Tj
16.41408 0.00001 TD
(There is dysfunction of)Tj
-16.41408 -1.15791 TD
0.245 Tw
(the parasympathetic and sympathetic systems in critically ill)Tj
0 -1.15789 TD
0.197 Tw
[(patients, which may relate to septic encephalopathy and CIP)111(.)]TJ
28.33011 67.99988 TD
0.03 Tw
(The absent SSR may explain the tendency to hypotension in the)Tj
0 -1.15789 TD
0.141 Tw
(critically ill patients.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 390.1944 709.1578 Tm
0 0 0 1 k
(9)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 395.7837 706.0228 Tm
0 0 0 1 k
0.141 Tw
(Dysfunction of sympathetic pathways in)Tj
-9.11828 -1.15789 TD
0.258 Tw
(the CNS probably explains the absent SSR in patients with)Tj
0 -1.1579 TD
0.014 Tc
0.361 Tw
[(anoxic-ischemic encephalopathy)65(, traumatic encephalopathy)65(,)]TJ
0 -1.15789 TD
0 Tc
-0.011 Tw
[(traumatic quadriplegia and Parkinson\325)55(s disease who did not have)]TJ
T*
0 Tw
(SIRS.)Tj
1.26316 -1.1579 TD
-0.024 Tw
(It seems unlikely that habituation from the repetitive action of)Tj
-1.26316 -1.15789 TD
0.042 Tw
(the ventilator stimulating the lungs would cause the absent SSR)Tj
T*
0.036 Tw
(since two of our patients with moderate to severe critical illness)Tj
0 -1.1579 TD
0.211 Tw
(polyneuropathy continued to have an absent SSR one month)Tj
0 -1.15789 TD
0.049 Tw
[(after dischar)18(ge from the ICU and of)17(f the ventilator)55(. )18(The median)]TJ
T*
0.075 Tw
[(nerve SNAP)-288(was normal in 21 patients, making it unlikely that)]TJ
0 -1.1579 TD
0.137 Tw
[(dysfunction of the af)18(ferent limb of the SSR accounted for the)]TJ
0 -1.15789 TD
0.088 Tw
[(absent SSR. Furthermore, none were on adrener)18(gic blockers or)]TJ
T*
0.095 Tw
[(drugs with anticholiner)18(gic properties that would block or blunt)]TJ
0 -1.1579 TD
0.293 Tw
[(the SSR. )18(This was a preliminary study; prospective studies)]TJ
0 -1.15789 TD
0.141 Tw
(should include repeat testing during and after the ICU stay in)Tj
T*
0.002 Tc
0.373 Tw
(well defined patient groups. Recording of the quantitative)Tj
0 -1.1579 TD
0 Tc
0.049 Tw
(sudomotor axon reflex)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
6.27 0 0 6.27 396.0923 522.1578 Tm
0 0 0 1 k
(8)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9.5 0 0 9.5 404.9134 519.0228 Tm
0 0 0 1 k
0.049 Tw
(would further establish the presence of)Tj
-10.0793 -1.15789 TD
0.018 Tw
(sympathetic dysfunction and determine if it is proximal or distal)Tj
T*
0.025 Tw
(to the sympathetic ganglia.)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F1 1 Tf
9.5 0 0 9.5 309.16 475.0228 Tm
0 0 0 1 k
(R)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F1 1 Tf
7.125 0 0 7.125 316.0183 475.0228 Tm
0 0 0 1 k
0.001 Tc
(EFERENCES)Tj
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
8.5 0 0 8.5 309.16 462.0228 Tm
0 0 0 1 k
(1.)Tj
1.88235 0 TD
0.02 Tc
0.427 Tw
(Bolton CF)Tj
4.72256 0 TD
(,)Tj
0.93 0 TD
0 Tc
(Y)Tj
0.64206 0 TD
0.02 Tc
(oung GB. )Tj
5.15481 0 TD
(The neurological consultation and)Tj
-10.27296 -1.05884 TD
0 Tc
0.297 Tw
(neurological syndromes. In: Bolton CF)Tj
16.74272 0 TD
(,)Tj
0.75972 0 TD
(Y)Tj
0.62207 0 TD
(oung GB, editors.)Tj
-18.1245 -1.05883 TD
0.013 Tw
(Balliere's clinical neurology: international practice and research.)Tj
0 -1.05882 TD
0.025 Tw
(Critical Care. London:Balliere )Tj
12.49688 0 TD
(T)Tj
0.57593 0 TD
(indall; 1996. p. 447-76.)Tj
-16.13164 -1.05883 TD
(2.)Tj
1.88235 0 TD
-0.03 Tw
(Bolton CF)Tj
4.08525 0 TD
-0.0001 Tc
(.)Tj
0.46931 0 Td
0 Tc
(Neuromuscular manifestations of critical illness. Muscle)Tj
-3.37809 -1.05883 TD
0.025 Tw
(Nerve. 2005;32:140-63.)Tj
-3.05882 -1.05882 TD
(3.)Tj
1.88235 0 TD
0.005 Tc
0.37 Tw
(Bolton CF)Tj
4.52869 0 TD
0.0046 Tc
(.)Tj
1.50446 0 Td
0.005 Tc
(Sepsis and the systemic inflammatory response)Tj
-4.85668 -1.05883 TD
0 Tc
0.004 Tw
(syndrome: neuromuscular manifestations. Crit Care Med. 1996;)Tj
0 -1.05882 TD
0 Tw
(24:1408-16.)Tj
-3.05882 -1.05882 TD
(4.)Tj
1.88235 0 TD
(T)Tj
0.57593 0 TD
0.012 Tw
(ran DD, Groeneveld, )Tj
8.61577 0 TD
(AB, van der Meulen, J, Nauta JJ, Strack van)Tj
-8.01522 -1.05883 TD
0.279 Tw
(Schijndel RJ, )Tj
6.12289 0 TD
(Thijs LG. )Tj
4.64097 0 TD
(Age, chronic disease, sepsis, or)Tj
13.62006 0 TD
0 Tw
(gan)Tj
-24.38391 -1.05883 TD
0.179 Tw
(system failure and mortality in a medical intensive care unit.)Tj
0 -1.05882 TD
0.025 Tw
(Crit Care Med. 1990;18:474-9.)Tj
-3.05882 -1.05882 TD
(5.)Tj
1.88235 0 TD
0.02 Tc
0.437 Tw
(Bolton CF)Tj
4.73246 0 TD
(,)Tj
0.9399 0 TD
0 Tc
(Y)Tj
0.64206 0 TD
0.02 Tc
(oung GB, Zochodone DW)Tj
12.19166 0 TD
(.)Tj
0.95893 0 TD
(The neurological)Tj
-18.28853 -1.05884 TD
0 Tc
0.025 Tw
(complications of sepsis. )Tj
9.85088 0 TD
(Ann Neurol. 1993;33:94-100.)Tj
-12.9097 -1.05883 TD
(6.)Tj
1.88235 0 TD
0.201 Tw
(Lacomis D, Zochodne DW)Tj
11.33947 0.00001 TD
-0.0001 Tc
(,)Tj
0.70046 0 Td
0 Tc
(Bird SJ. Critical illness myopathy)Tj
14.7143 0 TD
(.)Tj
-25.57776 -1.05883 TD
0.025 Tw
(Muscle Nerve. 2000;23:1785-8.)Tj
-3.05882 -1.05882 TD
0.103 Tw
[(7.)-1132(Rich MM, McGarvey ML, )17(T)70(eener JW)92(, Frame LH. ECG changes)]TJ
3.05882 -1.05882 TD
0.025 Tw
[(during septic shock. Cardiology)65(. 2002;97:187-96.)]TJ
-3.05882 -1.05883 TD
0.083 Tw
[(8.)-1132(Low P)91(A, Caskey P)92(A, Zuck RR, Fealey RD, Dyct PJ. Quantitative)]TJ
3.05882 -1.05882 TD
0.08 Tw
(sudomotor axon reflex test in normal and neuropathic subjects.)Tj
T*
0.025 Tw
(Ann Neurol. 1983;14:573-80.)Tj
-3.05882 -1.05882 TD
0.008 Tc
0.367 Tw
[(9)8(.)-1124(Ravitz JM, )55(AAEM Minimonograph #48. )54(Autonomic nervous)]TJ
3.05882 -1.05882 TD
0 Tc
0.025 Tw
(system testing. Muscle Nerve. 1997;20:919-37.)Tj
-3.05882 -1.05882 TD
0.004 Tw
[(10.)-632(Shahani BT)74(, Day )17(TJ, Cros D, Kahlil N, Kneebone CS. R-R Interval)]TJ
3.05882 -1.05882 TD
0.01 Tw
(variation and the sympathetic skin response in the assessment of)Tj
T*
-0.034 Tw
[(autonomic function in peripheral neuropathy)65(. )55(Arch Neurol. 1990;)]TJ
T*
0 Tw
(47:659-64.)Tj
-3.05882 -1.05882 TD
0.255 Tw
[(1)37(1.)-669(Kneebone CS. R-R interval variation and the sympathetic skin)]TJ
3.05882 -1.05882 TD
0.084 Tw
(response in the assessment of autonomic function in peripheral)Tj
T*
0.025 Tw
[(neuropathy)65(. )55(Arch Neurol. 1990;47:659-64. )]TJ
-3.05882 -1.05882 TD
0.05 Tw
[(12.)-632(Zochodne DW)91(, Bolton CF)80(, )18(W)80(ells GA, Gilbert JJ, Hahn )55(AF)79(, Brown)]TJ
3.05882 -1.05882 TD
0.262 Tw
[(JD, et al. Critical illness polyneuropathy)65(. )55(A)-457(complication of)]TJ
T*
0.025 Tw
[(sepsis and multiple or)18(gan failure. Brain. 1987;1)37(10:819-41.)]TJ
-3.05882 -1.05882 TD
0.252 Tw
[(13.)-632(Bolton CF)79(. Critical illness polyneuropathy)65(, In: Noseworthy JH,)]TJ
3.05882 -1.05882 TD
0.023 Tw
[(editor)55(. Neurological therapeutics. London: Martin Dunitz; 2003.)]TJ
T*
0.025 Tw
(p. 2229-36.)Tj
ET
0 0 0 0 k
39.024 726 516 30 re
f
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9 0 0 9 308.5412 749.8455 Tm
0 0 0 1 k
0.025 Tw
[(LE JOURNAL)-238(CANADIEN DES SCIENCES NEUROLOGIQUES)]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F3 1 Tf
9 0 0 9 39.024 29.4312 Tm
0 0 0 1 k
0.025 Tw
[(V)111(olume 34, No. 3 \320 )18(August 2007)]TJ
ET
Q
/GS2 gs
/GS1 gs
q
BT
/F0 1 Tf
9 0 0 9 540.524 29.4312 Tm
0 0 0 1 k
(315)Tj
ET
Q
endstream
endobj
30 0 obj
<<
/Filter /FlateDecode
/Length 238
>>
stream
xmK0[n2PrdI&ulvhalnu^R /{bى})buz)ǓJk[Z9tc!&yEPJ'[ITwPMό'9
Θ{>
endobj
32 0 obj
<<
/FontFile3 49 0 R
/XHeight 685
/Ascent 700
/Type /FontDescriptor
/StemV 79
/FontName /FLFRTK+Times-BoldItalic
/StemH 0
/CapHeight 669
/FontBBox [-200 -216 992 921]
/ItalicAngle -11
/Flags 262242
/Descent -204
>>
endobj
33 0 obj
<<
/Differences [32 /space 58 /colon 66 /B /C 70 /F 77
/M 80 /P 82 /R 97 /a /b /c /d
/e /f /g /h /i /j /k /l 110 /n
/o /p 114 /r /s /t /u 120 /x 142
/eacute]
/BaseEncoding /MacRomanEncoding
/Type /Encoding
>>
endobj
34 0 obj
<<
/FontFile3 50 0 R
/XHeight 677
/Ascent 684
/Type /FontDescriptor
/StemV 23
/FontName /TBSYQH+Times-Italic
/StemH 0
/CapHeight 654
/FontBBox [-169 -217 1009 884]
/ItalicAngle -11
/Flags 98
/Descent -205
>>
endobj
35 0 obj
<<
/Differences [32 /space 40 /parenleft /parenright 44 /comma /hyphen /period /slash
/zero /one /two /three /four /five 55 /seven 58 /colon
/semicolon 65 /A /B /C /D 74 /J 76 /L
78 /N 82 /R /S /T 86 /V 89 /Y
97 /a /b /c /d /e /f /g /h /i
108 /l /m /n /o /p /q /r /s /t
/u /v /w /x /y 208 /endash]
/BaseEncoding /MacRomanEncoding
/Type /Encoding
>>
endobj
36 0 obj
<<
/FontFile3 51 0 R
/XHeight 677
/Ascent 684
/Type /FontDescriptor
/StemV 84
/FontName /VOZEJR+Times-Roman
/StemH 0
/CapHeight 662
/FontBBox [-168 -218 1000 899]
/ItalicAngle 0
/Flags 34
/Descent -215
>>
endobj
37 0 obj
<<
/Differences [32 /space 35 /numbersign 37 /percent 39 /quotesingle /parenleft /parenright
44 /comma /hyphen /period /slash /zero /one /two /three /four
/five /six /seven /eight /nine /colon /semicolon 65 /A /B
/C /D /E /F /G /H /I /J /K /L
/M /N /O /P /Q /R /S /T /U /V
/W 89 /Y /Z 97 /a /b /c /d /e
/f /g /h /i /j /k /l /m /n /o
/p /q /r /s /t /u /v /w /x /y
/z 136 /agrave 142 /eacute /egrave 213 /quoteright]
/BaseEncoding /MacRomanEncoding
/Type /Encoding
>>
endobj
38 0 obj
<<
/FontFile3 52 0 R
/XHeight 921
/Ascent 912
/Type /FontDescriptor
/StemV 25
/FontName /EXEQBN+Times-Bold
/StemH 0
/CapHeight 676
/FontBBox [-168 -218 998 934]
/ItalicAngle 0
/Flags 262178
/Descent -203
>>
endobj
39 0 obj
<<
/Differences [32 /space 45 /hyphen /period 58 /colon 65 /A /B
/C /D /E /F /G 73 /I 76 /L /M
/N /O 82 /R /S /T /U /V 97 /a
99 /c /d /e /f 104 /h /i 107 /k
/l /m /n /o /p /q /r /s /t /u
/v 121 /y /z 131 /Eacute 142 /eacute 213 /quoteright]
/BaseEncoding /MacRomanEncoding
/Type /Encoding
>>
endobj
40 0 obj
<<
/Type /Font
/Subtype /CIDFontType2
/BaseFont /AAANBE+NotoSans
/CIDSystemInfo 53 0 R
/FontDescriptor 54 0 R
/W [0 [600]
3 [260]
17 [268 372 572 572]
22 [572]
25 [572 572]
28 [572 268]
38 [632]
51 [605]
54 [549]
56 [731]
68 [561 615]
71 [615 564]
74 [615 618 258]
79 [258 935 618 605 615]
85 [413 479 361 618 508]
92 [510]
]
/CIDToGIDMap 55 0 R
>>
endobj
41 0 obj
<<
/Filter /FlateDecode
/Length 327
>>
stream
x]j0^,]aqEf\Ct/|90_LL